ADA Partners with DEA on Opioid Epidemic Webinar
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
Align Technology has announced that Jennifer L. Davis will succeed Joseph M. Hogan as president and chief executive officer, effective December 31, 2026. Davis, former CEO of Procter & Gamble's global healthcare business, brings 33 years of industry experience to lead the company's next phase of digital oral health growth.